PDPN and melanoma: Immunofluorescence analysis further revealed that β-catenin expression is significantly reduced in A375 and B16-F10 melanoma cells following PDPN knockdown, and that both total and S552-phosphorylated β-catenin levels are significantly decreased upon PDPN depletion or CY12-RP2 treatment (Figures 4B, C).